Legal & General Group
RXII

Legal & General Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Legal & General Group’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-23,219
Closed -$8K – 3327
2016
Q3 		$8K Hold
23,219
– – ﹤0.01% 2857
2016
Q2 		$10K Hold
23,219
– – ﹤0.01% 2885
2016
Q1 		$32K Hold
23,219
– – ﹤0.01% 2575
2015
Q4 		$34K Hold
23,219
– – ﹤0.01% 2610
2015
Q3 		$35K Hold
23,219
– – ﹤0.01% 2611
2015
Q2 		$39K Hold
23,219
– – ﹤0.01% 2632
2015
Q1 		$33K Hold
23,219
– – ﹤0.01% 2642
2014
Q4 		$35K Hold
23,219
– – ﹤0.01% 2577
2014
Q3 		$49K Buy
+23,219
New +$49K ﹤0.01% 2398

Legal & General Group's RXII Position: Q4 2016 in Review

Legal & General Group sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 23,219 shares — an estimated $8K sold.

Legal & General Group first reported a position in RXII in Q3 2014 and held it in 9 quarters. The position peaked at $49K in Q3 2014. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

  • Legal & General Group reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
  • Legal & General Group sold 23,219 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $8K.
  • Legal & General Group first reported a position in GALENA BIOPHARMA INC COM in Q3 2014 and held it in 9 quarters.
  • Legal & General Group's GALENA BIOPHARMA INC COM position peaked at $49K in Q3 2014.
  • 0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Legal & General Group's 13F filing for Q4 2016, filed 13 Feb 2017.